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Response of intestinal cells of differing topographical and
hierarchical status to ten cytotoxic drugs and five sources of
radiation
K. Ijiri* & C.S. Pottent
Paterson Laboratories, Christie Hospital and Holt Radium Institute, Withington, Manchester M20 9BX.
Summary The spacial distribution of cell death among the epithelial cells lining the adult mammalian small
intestinal mucosa at various times after a range of doses of 10 different drugs as well as after internal or
external irradiation (f particles from tritium, y- and X-rays and neutrons) has been recorded. Cell death,
expressed as pycnosis or apoptosis, has been recorded for each cell position up the side of the crypts of the
small intestine. The results, in the form ofdistributions of dead cells at each cell position, show that each of the
various cytotoxic agents tends to act preferentially over a characteristic small range of cell positions. Since cell
position is likely to be related to hierarchical cell position within a family tree or cell lineage, each agent tends
to act with greatest efficiency on cells at a particular position within the lineage.
Adriamycin and the various forms of radiation tend to kill cells preferentially at cell position 4-5 i.e. on
cells very early in the lineage, probably stem cells. Isopropyl-methane-sulphonate, nitrogen mustard and
possibly Actinomycin-D act on cell position 6-7, while 5-fluorouracil, Myleran, cyclophosphamide, and
cycloheximide tend to kill cells at cell position 7-9. Vincristine and hydroxyurea are the 2 agents that exhibit
a specificity for cells highest up the crypt, i.e. latest in transit population of the cell lineage by acting on cell
positions 10 or 11. The data also suggest that normal healthy cells continue to migrate up the crypt and onto
the villus in spite of considerable cell death and reduced cell production.
Cytotoxic agents that are of therapeutic interest
commonly act on proliferative cells or on
proliferating cells at a particular phase of their cell
cycle. For the most part it is assumed that all cells
passing through the cell cycle will be equally
affected. However, it is possible that cells of
differing hierarchical status may respond in their
own characteristic fashion with a characteristic
sensitivity. This can be explored in the highly
structured surface epithelia.
The epithelial cells lining the adult mammalian
small intestinal mucosa (villi and crypts) represent
an hierarchical cell lineage that can be related to
the tissue architecture. The suggestion that cell
replacement within the crypts of the small intestine
can be described by a cell lineage, or series of cell
lineages, with one or a relatively small number of
lineage ancestor cells-stem cells-has been made
by many authors (e.g. Quastler & Sherman, 1959;
Cheng & Leblond, 1974; Potten 1980; Potten et al.,
1982) (see Figure 1). The precise number of non-
migrating lineage ancestor cells remains uncertain
but in mice is probably less than 16, the number of
cells in a circumferential section through the crypt.
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From the general polarity of the tissue, cell
migration, cell kinetic and regeneration studies, the
position within the crypt of the various generations
within the cell lineage can be deduced, with the
stem cells being scattered amongst locations near
the base of the crypt (i.e. positions below the fifth
cell position) (Cheng & Leblond, 1974; Cheng &
Bjerknes, 1980; Bjerknes & Cheng, 1981; Potten,
1980; Potten et al., 1983; Potten & Hendry, 1983).
The base of the crypt contains several mature and
immature Paneth cells. The Paneth precursors and
putative stem cells cycle at a slower rate (T,=15-
36h) than the majority of proliferating crypt cells
situated at higher positions (T = 11 h for cell
positions 6-20). Above these are several cell
positions where no proliferative activity can be
detected, i.e. the region of post-mitotic maturing
columnar and goblet cells which migrate onto the
villus where they perform their function, become
senescent and are shed from the villus.
Thus, by studying the behaviour of cells at
different positions within the crypt it is possible to
study the behaviour of cells of different hierarchical
status. Differences in hierarchical status
(differentiation/maturation) might be expected to be
associated with differences in cell cycle progression
rate, microenvironment, microvasculature or cell
metabolism and some, or all of these might result in
differences in the response of cells to various
cytotoxic agents. Here, dead or dying cells (recorded
as the appearance of histologically recognisable
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Figure 1 Schematic representation of longitudinal section of a crypt showing the method of numbering the
cells from the base to the top of the crypt. A=Apoptotic cells (or apoptotic fragments which are often
clustered). P=Paneth cells with Paneth granules, G=Goblet cells, M=Mitosis, E=Enteroendocrine cell, S
=Stem cells, F=Pericryptal Fibroblast. The proliferative zone is indicated as well at the stem cell region. On
the right a possible cell lineage for cell replacement in the crypt is shown. The entire crypt could be regarded
as originating from a single primary (ultimate) stem cell (S') in which case there would be 7 amplification
divisions (generations). Alternatively there may be about 12 lineage-originators (stem cells) e.g. those cells
within the lower dashed box. In this case 3 amplifying transit divisions would be expected. All the cells within
the lower dashed box could be regarded as identical stem cells (S). However, they may be positioned at
different levels (a-e) in relationship to a hypothetical stem cell milieu or focal point (a). The position relative
to the focal point may determine the cell cycle duration (Go duration) and self-maintenance (differentiation)
probabilities (see Potten et al., 1979). This operational heterogeneity may extend even further to include more
cells (lower and upper dashed boxes) e.g. the clonogenic fraction (- 80 cells). In this case only one further
amplifying cell division would be expected. The diagram reflects the uncertainty in our knowledge on the
precise number of stem cells. The approximate cell position within the crypt for each cell generation is also
indicated (right hand side).
dead cells, apoptosis, within a short time of
treatment) have been scored at each cell position
within crypts at various times after exposure to a
wide range ofcytotoxic agents. The results show that
each agent has a certain selectivity for a particular
cell position along the crypt and hence hierarchical
status.
Materials and methods
Animals
Ten-12-week-old male B6D2F1 (Pat) mice (-25g)
were used throughout the experiments. The animals
were kept under a 12h dark (18.00-06.00), 12h light
regimen, and were given food and water ad libitum.
Drugs
All drug solutions were made up immediately
before use, and dilutions were carried out either in
0.9% saline or in sterile water (except for Myleran,
which was dissolved in arachis oil). All injections
involved 0.2ml given i.p. at 09.00h. Drug doses
injected in this volume are quoted as mg per mouse
(1 mg per mouse is 40mgkg-1). Cytotoxic drugs
used were: isopropyl-methane-sulphonate (IMS,
Koch-Light, Colnbrook); Myleran (R), (MY,
Burroughs-Wellcome, busulphan, 1, 4-dimethane
sulphonyl oxybutane); cyclophosphamide (CP,
Endoxana (R), WB Pharmaceuticals, Bracknell),
vincristine (VCR, Oncovin (R), Lilly, Basingstoke);
hydroxyurea (HU, Sigma, Poole) and cycloheximide
(CH, Sigma, Poole). The results presented here for
mechlorethamine (HN2, mustine hydrochloride,
Boots, Nottingham); 5-fluorouracil (5FU,
Fluorouracil (R), Roche, Welwyn Garden City);
actinomycin-D (ACT, Cosmogen (R), Merck Sharp
and Dohme) and adriamycin (ADR, Montedison,
Barnet, Hertfordshire) are unpublished results fromINTESTINAL CELL DEATH 177
Table I Cytotoxic agents, range of doses and post-treatment sampling times for
which apoptotic distributions were obtained
Tine ofsampling after
Agent Doseper mouse treatment (h)
Alkylating agents
IMS
MY
CP
HN2
Antimetabolites
5FU
HU
CH
Antibiotics
ACT
ADR
Strathmokinetic agents
VCR
Radiation
Internal p[3 TdR
External 137Cs y-rays
300kVp X-rays
0.1mg
1.0
10.0
1.0mg
3.0
0.1mg
1.0
10.0
0.043mg*
2.9mg*
0.1mg
1.0
10.0
5.0
0.017mg*
0.23mg*
0.01mg
0.1
5.0pCi
50
500
0.22Gy(4.5Gymin-)
0.63
12.0
14.0
0.005Gy(0.6Gymin )'
0.09
0.15
3+
3, 6, 12
3, 6, 9, 12
6,9, 12
5.5
3+
9, 12
3+,6,9,12
1+,3,5,7,10, 12
1+,3+,5+,7, 10, 12
3+,6+
3, 3.5, 6.5
3, 4, 5, 6, 9, 12
1+,2,3,6, 12
1+,3,5,7,9,11, 12
3+,6,9, 12
3, 6, 9, 12
6+
3.5+,6,6.5,9, 12
6
3
3
3.6, 9, 12
3, 6
3+
3+
3
14.7MeV neutrons
600MeV neutrons
0.075Gy(0.005Gymin 1)' 3
0.15(0.0027Gymin-')' 3
*Data kindly supplied by Dr. J.V. Moore.
aFull description of the technical details are presented elsewhere (Hendry et al., 1982).
'Distributions not analysed because the absolute yield was too low (i.e. < 1.5
apoptotic cells per crypt section).
Dr. J.V. Moore which will be presented in full Irradiation
elsewhere. The data were recorded in the same way
but slightly different criteria were used to define External irradiation was achieved using a137CS_y_ dead or dying cells. Table I shows the range of irradiator designed for whole-body irradiation of
doses and post-treatment sampling times studied. small animals at a dose rate of 4.5Gyminm .178 K. IJIRI & C.S. POTTEN
Irradiation was performed between 09.00-09.30h.
Some data using X-rays or neutrons which have
been published elsewhere (Hendry et al., 1982) were
also re-analysed here. Internal irradiation was
achieved by f-irradiation from tritiated thymidine
([3H]TdR, Amersham International). Doses ranging
from 5.0 Ci to 5004uCi per mouse were delivered in
0.1 or 0.2ml. The specific activity varied from 5-
25CimM-'.
Sample preparation
Three to 4 animals were used per experimental
point. At various times (1-12h) after administration
of agents, mice were killed by cervical dislocation.
The complete small intestine was fixed in Carnoy's
fixative for 30min prior to storage in 70% ethanol.
The ileum was then cut into 1 cm lengths, 10-12 of
which were placed together enclosed in surgical
tape, trimmed, embedded in paraffin and sectioned
transversely at 5gm. These sections were stained
with hematoxylin and eosin and used to score dead
or dying cells.
Apoptosis
Apoptosis (Kerr et al., 1972) (initially called
shrinkage necrosis, Kerr, 1971) was described as a
controlled process of cell deletion involving nuclear
(pycnotic) and cytoplasmic condensation, fragment-
ation (karyorrhexis) and commonly phagocytic en-
gulfment by healthy neighbouring cells. Apoptosis
occurs in normal and tumour tissue and its yield
is enhanced by various cytotoxic agents (Searle et
al., 1975). Cells undergoing cell death were easily
recognised in crypt sections particularly by their
chromatin condensation (marginal initially) and the
subsequent cellular fragmentation and engulfment
and presented an appearance very similar to that
previously described as apoptosis. The yield of
apoptotic fragments differs from the yield of
pycnotic fragments only slightly (by an amount
roughly equivalent to the proportion of fragments
that consist of cytoplasm only). Vincristine arrests
cells in mitosis, some of which (the number depends
on dose and particularly time) will die in mitosis
and become pycnotic. No distinction has been made
here between this type of death and the defined
sequence of changes for which we use the term
apoptosis, since our interest was merely to obtain
some measure of the amount of cell death at each
position in the crypt.
Scoring ofapoptosis
Good longitudinal sections of crypts were selected
i.e. crypts sectioned so that the base (marked by
Paneth cells), middle and top of the crypt were all
in the plane of section (and hence the crypt lumen
was usually visible). Starting at the base of the crypt
column the cells were numbered up each side as
shown in Figure 1 and the cell positions containing
apoptotic fragments were recorded up to the 30th
cell position which represents' the highest level for
the occurrence of apoptosis for most agents over
the time-scale studied. The crypt end (the junction
with the villus) was also recorded but this is a
somewhat subjective end-point. For each
experimental group, 100-400 half crypts were
scored and a frequency versus cell position
distribution was obtained, each of which consisted
of between 140-900 apoptotic fragments. If several
apoptotic fragments were, from their size and
clustering, thought to represent the remains of a
single cell, they were also recorded as a single
apoptotic cell. When this value was used the data
were referred to as apoptotic cells. For the
distribution of spontaneous apoptosis (control) 1400
half-crypts were scored from 7 mice, yielding 206
apoptotic fragments (184 apoptotic cells) in total,
i.e. 0.13 apoptotic cells per half crypt section or 0.26
per crypt section. This is slightly higher than the
24h average for the yield of apoptotic cells per
crypt of 0.17 reported earlier (Potten et al., 1977),
but is consistent with the values above 0.2 observed
at certain times of the day.
Distributions were only analysed if the total
average yield exceeded 1.5 apoptotic cells (i.e.
clumped fragments) per crypt section i.e. were - 10
times the control level. In this way drug- or
radiation-induced cell death was distinguished from
the spontaneous cell death.
Myleran resulted in a different response in that
peak values were not obtained until about 12h
post-treatment even though elevated values were
obtained at earlier times. At these earlier times the
yields did not exceed about 1.0 apoptotic cells per
crypt section. In order that we could obtain some
preliminary information on the position of
maximum effects, distributions were obtained by
using selected crypts with many apoptoses.
Analysis ofthe distributions ofapoptoticfragments
For each dose of an agent and for each post-
treatment time interval a distribution of apoptotic
fragments for each cell position was obtained. These
distributions were generally spread over many cell
positions and were fairly symmetrical or slightly
skewed to the right (representative examples are
shown in Figure 2). Three parameters were
calculated that describe each distribution; 1) a
measure of central tendency, the median cell
position of the distribution (xmcd), 2) a measure of
the spread of the right half of the distribution (the
s.d. of the right half, o,, and 3) a similar measure of
the spread of the left half of the distribution (al).INTESTINAL CELL DEATH 179
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Figure 2 Typical apoptotic distribution after various
cytotoxic agents. HU (10mg, 3h), y-rays (14.0Gy, 3h),
CP (lOmg,6h) and CH (5mg, 6h).
Apoptotic frequency at each cell position is shown
as the percentage of the total apoptotic frequency.
In each distribution, the three parameters (Xmed, ,r
and a,) described in the text are shown. The vertical
broken line represents the median point, while the
horizontal lines show the extent of a, and 0,, which are
measures of spread of the right or left halves of the
distribution, respectively.
These are illustrated in Figure 2 and defined more
precisely in the Appendix.
Figure 1 illustrates a typical crypt section and
a cell lineage that can account for the cell
replacement. It is clear that the cells early in the
lineage must be located towards the crypt base
while those late in the lineage must be present at
the top of the crypt. In fact the position of a cell
within the lineage (hierarchical status) may be fairly
precisely related to a spatial location (cell position)
within the crypt as suggested on the right of the
diagram.
The results for each dose and post-treatment time
(i.e. each distribution) are summarised by the 3
parameters described above. The median values
(approximately the cell position for maximum effect)
have then been plotted against the value for the s.d.
from the median and all the results for a single
cytotoxic agent have been enclosed within a
polygon defined by the outermost points. This
approach has been adopted in an attempt to
represent the full distribution by a single value that
gives some indication of the cell position most
affected by the cytotoxic agent.
Results
Figure 3 shows how, for each cytotoxic agent, all
values for xmed and ar for a range of doses and
different sampling times tend to cluster within a
characteristic area i.e. for each cytotoxic agent there
is a characteristic range of cell positions most
affected and for some agents a rather characteristic
amount of spread for the right half of the
distribution i.e. spread up the crypt. In some cases
the clustered points for various agents are well
separated e.g. radiation (external, or internal from
[3H] TdR) and HU; in other cases there is some
overlap. There was no clear trend in the changes of
Xmed or a, when different doses of any one agent
were considered. However, there is a tendency for
both xmed and ar to increase with increasing time
after exposure to any one agent (see the HU data
on Figure 3 which are typical. The first number
represents the dose in mg/mouse and the second
number is the post-treatment time in hours).
Since all the agents tested kill cells, which then
take some time firstly, to change their appearance
and secondly, to disappear, the number of cells
along the side of the crypt will gradually decrease
with increasing time after exposure to these
cytotoxic agents as the dead cells are engulfed,
carried up to the crypt, and digested. Furthermore,
with increasing time, healthy cells continue to move
out of the crypt in many cases without
compensatory replacement cell divisions. Thus, a
given cell position, defined by counting the number
of cells some time after exposure to a drug or
radiation may not be equivalent to the same
position (e.g. distance from the base in gm) in
untreated animals. For instance 12h after HU the
21st cell may, in fact, be at a position that was
occupied by the 24th cell in unirradiated controls. In
eachcase an attempt was madetodefine the topofthe
crypt by virtue of the position of the villus and the
alignment of crypt and villus cells. In untreated
animals the average number of cells to this point180 K. IJIRI & C.S. POTTEN
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Figure 3 Cytotoxic response of crypt cells at different cell positions to various cytotoxic agents. For each
apoptotic distribution, the median (xmed) and a measure of the spread, the "standard deviation from the
median" of the right half, (a,) have been calculated and plotted (see text). All the points plotted represent
results obtained over the first 12h after the exposure to various doses of cytotoxic agents. The points for each
agent are enclosed by a solid or broken line. There has been no correction for difference in crypt size (see text
and figure 4). The dose in mg per mouse and the time after treatment is shown for each point for one agent
(HU) e.g. 1-3 and 10-6 represent 1.0mg-3h and 10.0 mg-6h, respectively. The untreated control value is also
shown by the double circle. The results for 3 agents are plotted separately on the lower graph for clarity.
was -24. For early times there was no change in
this value since dead cells may still occupy a cell
position and healthy cell emigration is insignificant.
However, by 12h the number of cells to the top of
the crypt could be reduced to values typically 20.
In an attempt to correct for this effect the
distributions were adjusted by a factor (F) given by
F=A/B, where A=average number of cells to the
top of the crypt in untreated animals and B
=average number to the top of the crypt in treated
animals. Figure 4 shows the data from Figure 3
corrected in this fashion. The same general
conclusions can be drawn even though the shape of
the polygons is changed in most cases. The spread
to the left side of the distributions, a, (Figure 5) is
much less with the smallest spread when Xmed is low
(since the bottom of the crypt is then close to Xmed
little spread can be expected) and the highest spread
when xmed is large (see Table II).
The spread of the points within each area
describing a particular drug is largely the
consequence of changes in the distributions with
time (see Figure 3). These are usually associated
with a movement of the median value to higher cell
positions and an increase in the spread of the
distribution (especially Cr). This is probably the
consequence of the fact that the dead cell fragments
are ingested by neighbouring living cells which
continue to move up the crypt and on to the villus
(see below). If this is the case then the migration
velocity of these apoptotically "marked" healthy
cells can be calculated using any arbitrary point on
the distribution. Three points were selected and
velocity measurements were made using
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Figure 4 The data shown in Figure 3 corrected for differences in crypt size (standardised to 24 cell positions
per crypt, see text). (Otherwise as for Figure 3).
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Table II Range of median and standard deviation values taken from Figures
3 and 4 for the various doses and times
Uncorrected Corrected
Agent U at Xmed r Xmed
ADR 3.2-4.3 1.9-2.4 4.3-5.0 3.8-5.2 4.7-5.9
Radiation
external 3.5-5.5 2.3-3.4 4.2-6.7 3.8-5.7 4.6-7.3
internal 4.1-4.7 2.6-3.3 4.9-6.4 4.4-4.7 5.1-6.7 NS
HN2 4.3-5.3 3.0-3.8 6.3-7.3 4.4-6.3 7.0-8.6
IMS 4.2-5.7 3.1-3.5 5.8-7.4 4.6-6.5 5.7-8.8 <0.05*
ACT 4.0-4.7 2.8-3.3 6.6-8.0 4.9-5.7 8.1-9.5
SFU 3.8-4.5 3.5-3.9 7.1-8.5 4.1-5.3 8.3-9.5
MY 4.1-6.0 3.4-4.3 6.4-8.7 4.3-5.9 6.2-9.1 =0.07(NS)
CP 4.5-5.9 3.5-4.3 7.3-8.7 4.5-6.0 7.4-8.7 <0.0001*
CH 5.7-9.9 3.6-4.0 7.7-9.2 5.4-9.2 7.3-8.8 <0.0001*
HU 4.2-6.4 3.9-5.2 8.6-12.2 4.7-7.2 9.8-12.7 <0.0001*
VCR 5.5-7.9 4.5-5.6 9.7-11.5 6.0-8.0 9.8-13.3 <0.0001*
*The six hour distributions were found to be significantly different from
those for y-irradiation (12Gy) using the Mann-Whitney U-test. This test makes
no assumptions about the underlying distributions.
distributions that have been corrected for changes
in crypt size. The 3 points chosen were Xmed which
roughly corresponds to cell positions 6-9 (i.e.
velocity of cells at low crypt positions), xmed
+0.674 o, which is equivalent to a point that
marks three-quarters of the total distributions and
this corresponds to cell positions 9-13 (i.e. mid-
crypt positions) and Xmed+1.177u,, which is
equivalent to the point at half the peak height,
corresponding to cell positions 12-17 (i.e. upper
crypt positions). An analysis of the velocities (using
the distributions for times up to 12h post-treatment
for IMS, CP and HU) showed that the cells located
within cell position 6-9 were moving at a rate that
is roughly equivalent to 0.25-0.35 cell positions per
hour, while the cells in the middle of the crypt (cell
positions 9-13) were moving with a velocity
equivalent to 0.35-0.45 cell positions per hour. The
cells towards the top of the crypt, where the
maximum velocity is to be expected (cell positions
12-17), were moving with a velocity equivalent to
0.45-0.55 cell positions per hour. The maximum
migration velocities (for the upper cell positions)
may be slightly lower at 0.30-0.35 cell positions per
hour for external radiations, 5FU, HN2 and VCR.
The maximum velocities for [3H] TdR, ADR and
ACT are lower still at 0.15-0.20 while the cells in
crypts exposed to CH show little or no sign of
movement at all (depending on the method of
calculations, CH may even generate negative
values). At times longer than 3h after VCR cells
escape the mitotic block or die (become normal GI
cells or pycnotic cells). If they become pycnotic they
enter the distribution of dead cells (for convenience
called apoptotic cells). Once dead they can become
engulfed by neighbouring cells and carried up the
crypt. Based on distributions obtained using 2 doses
of VCR and sampling times of 3-12h, the VCR-
induced dead cells are carried by healthy
neighbours at a velocity of about 0.3 cell positions
per hour. The results after CH are not typical of the
rest. Some dead cells appear at high crypt positions
and even on the villus soon after treatment (i.e. the
values for or for the early times are high). With
increasing time these high-level apoptoses disappear
(probably by lysosomal lysis) while in the mid-crypt
they disappear more slowly or are being
continuously produced. Hence with time after CH,
or decreased whereas for most agents it normally
increased. In rats, Altmann (1975) has reported
somewhat similar effects, namely nectrotic cells on
the villus (particularly the villus tip) within a few
hours of treatment and extrusion of dead or dying
cells (condensed cytoplasm and chromatin) into the
lumen of the crypt. These cell migration studies will
all be presented in greater detail elsewhere.
Discussion
The position of apoptotic cells after exposure to a
cytotoxic agent is influenced by several factors: (a)INTESTINAL CELL DEATH 183
the position of the sensitive target cells at the time
of exposure; (b) the migration of the cells between
exposure and the first detectable apoptotic change;
(c) the subsequent movement of the apoptotic cells
or cell fragments, which will depend on whether or
not they are engulfed by neighbouring migrating
epithelial cells, non-migrating stem cells or even the
slowly downward-migrating Paneth cells. If they are
not engulfed they may be lost to the crypt lumen;
(d) the rate of disappearance of the engulfed cells
through digestion; and (e) the changes in crypt size
caused by cell death and cell migration in the
absence ofcell replacement.
The estimated migration velocities will be lower
than those estimated from studies on the movement
of [3H] TdR labelled (healthy) cells because of
some of the points outlined above and particularly
since some apoptoses will be incorporated into non-
migrating cells. Some may be engulfed by
infiltrating non-epithelial cells (e.g. macrophages,
Elmes & Jones, 1980) and some may be lost directly
into the crypt lumen. Hence, these data should not
be taken as providing estimates for the normal
crypt cell migration velocity but merely as
indicative of the continued migration of cells after a
severe cytotoxic insult, i.e. under conditions of
reduced crypt cell numbers and reduced mitotic
activity. The velocity measurements do not depend
on any particular assumptions concerning the
precise shape of the apoptotic distributions.
However, they may be influenced by the rate of
digestion of the engulfed bodies (i.e. the half-life of
the apoptotic cells). Relatively little is known about
this but it is probably only a few hours (Potten et
al., 1978). This is supported by the observation that
for most agents few apoptoses are seen on the mid-
and upper-villus even at the later times.
For some of the agents tested, e.g. particularly
CH but also HU and VCR and occasionally CP
and IMS, apoptotic fragments could be observed at
positions beyond the end of the crypt especially for
the samples taken at later times after treatment (CH
excepted). This supports the idea that cells carrying
apoptotic fragments are moving and that they do
eventually reach at least the base of the villus.
However, the lysosomal digestion of these fragments
by the engulfing cells probably accounts for the fact
that apoptotic fragments are not seen further up the
villus.
There have been recent studies where various
normal properties, as well as a range of cellular
responses to irradiation, have been studied at each
cell position within the crypt (Potten et al., 1982,
1983; Potten 1983; Potten & Hendry, 1983). The
normal features of the cells that may vary with cell
position include: cell cycle kinetics, susceptibility to
factors controlling circadian rhythms and some
aspects of thymidine metabolism. Amongst the
responses to irradiation the ability of some cells to
continue migration and to continue to enter mitosis
or DNA synthesis appears to be unimpaired. It is
also possible that cells at different positions handle
their DNA strands in a particular way or undergo
differing levels of spontaneous sister chromatid
exchanges (Cairns, 1975; Potten et al., 1978, 1979).
When different radiobiological end-points are
considered the data suggest that the response of
cells (i.e. their radiosensitivity) may vary
considerably according to their spatial and
hierarchical position. Some cells at low cell
positions are very radiosensitive (Potten, 1977)
while cells late in the transit population are very
radioresistant (Potten et al., 1983).
Meistrich et al. (1982) have recently reported on
the cytotoxic efficiency of 14 drugs on the cells
within the spermatogenic hierarchy. Unfortunately
only three of the drugs (HN2, ACT and 5FU) were
the same as those used in the present studies.
Analysis of sperm counts on the 29th and 56th day
after treatment provided an indirect measure of cell
killing of differentiated (A1 through to intermediate
spermatogonia) and spermatogonial stem cells,
respectively. Triethylenethiophosphoramide (thio-
TEPA) and ADR were very effective against stem
cells in the mouse but ADR was not very effective
in humans. ADR produced results in the crypt that
also suggests a strong effect against stem cells
(Table 2). ACT and 5FU were moderately effective
against stem cells together with bis-
chlorethylnitrosourea, chlorambucil, mitomycin
C and procarbazine, while contrary to the present
results HN2 was found to be relatively ineffective
against stem cells. 5FU was also found to be very
efficient at killing differentiated spermatogonia. An
earlier report showed that HU, cytosine arabinoside
and the vinca alkaloids including VCR, as well as
CP, were also effective against differentiated
spermatogonia (Lu & Meistrich 1979). 5FU and cis-
platinum killed spermatocytes while cis-platinum
also killed spermatids. Although it is difficult to
make direct comparisons because of the differences
in the cell system and the method of scoring, it is
clear that in the testis the sensitivity of cells to
cytotoxic agents varies according to their
hierarchical status i.e. the spermatogenic cells
respond in a similar general fashion but not always
the same specific fashion, to the response in the
intestine.
The position of the presumptive target cells at the
time of treatment (t=0) can be deduced from the
back extrapolation of the regression line obtained
when the median values for each cytotoxic agent are
plotted against time. The estimates obtained in this
way are as follows: [3H] TdR, 4.1; ADR, 4.7; IMS,
4.9; y rays, 5.5; CP, 6.1; HN2, 7.1; ACT, 8.2; 5FU,
8.4 and HU 8.9. For VCR the situation is more184 K. IJIRI & C.S. POTTEN
complex and dose dependent (details to be
presented elsewhere) but the value is 10.5-12.0.
The major feature of the results presented here is
that each cytotoxic agent appears to have some
specificity for cells at a particular position within
the crypt and in some cases a rather characteristic
amount of spread in the distribution. Thus, each
cytotoxic agent illustrates some specificity for cells
of a particular hierarchical status. ADR kills cells
particularly towards the base of the crypt, the
median of the distributions is at about cell position
5. Radiation behaves in a similar fashion but
possibly centres on cell position 6. HN2 and IMS
attack cells around cell position 7 while ACT, 5FU,
MY, CP and CH all appear to have median values
at about cell position 8. Of the agents tested HU
and VCR attack the highest cell positions (latest
transit cell populations) centering on cells at about
position 10-11. These values are somewhat
approximate and vary slightly depending on
whether the corrected or uncorrected data are
considered (Table II) but the trend is clear. Since
the stem cells, or clonogenic cells (Figure 1) are
assumed to be located at the lower cell positions,
agents towards the top of the list in Table 2 might
be expected to kill stem cells or clonogenic cells and
hence sterilise (destroy) crypts while those towards
the bottom of the list might be expected to be
inefficient crypt sterilising agents. However, the
precise relationship between histological cell death
and reproductive sterilisation in this system awaits
clarification (see also Hendry & Potten, 1982).
There are a few noteworthy features that are
apparent from Table II: 1). Agents commonly
thought of as S-phase "specific", may indeed be so
in that they act with at least some specificity for S-
phase cells, but they may act on quite different
(positionally and hierarchically) S-phase cell
populations e.g. HU, [3H] TdR and ADR. That is,
there is some inherent, or environment determined,
heterogeneity amongst the S-phase cells 2) Agents
commonly regarded as cytotoxic for proliferating
cells may indeed be so but might have little effect
on the important stem cell compartment e.g. HU,
CP, MY, 5FU and possibly ACT. MY has been
thought to show some specificity for cells early in
the hierarchy in testis (Fox & Fox, 1967) and in
bone marrow (Schofield, 1978) but apparently does
not show a similar specificity here.
These studies suggest that it may be possible to
concoct "cocktails" of drugs that would selectively
eliminate any, or all, of the hierarchical intestinal
cells.
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Appendix
Three parameters (Xmed, a. and a, were calculated
as follows:
When fi is the frequency of cells with apoptotic
fragments at the i-th cell position (i=1, 2, ..., n) and
N=Z= fi is the total number of cells with
apoptotic fragments,
1) median cell position (xmed) is defined as
N m-i
xmed=m-+ f(1)
Here, m is the integer which satisfies
m-i N m
fi<-< E fi i=i '2 i=
2) The measure of the spread of the distribution to
the right of the median, the "standard deviation of
right half (v,) from the median" is defined and
obtained by the following equation
Ur N-i { L (i 2 Xm.d)2fi
+( 2 (=fX-2)} (2)
3) The measure of the spread to the left of the
median "standard deviation of left half(a,) from the
median" is defined by
2 m-1
1N(1 i ( rn-i )}
m+ ( 2Xmed
2 (__EN )
The second term in each equation (2) or (3),
expresses the variance from the median of the data
at the m-th cell position to the right (or left) of the
median.
Note that the measure of spread of each half of
the distribution (split by the median of the total
distribution) is calculated as the deviation of each
value from that median (not the mean) and is thus
referred to as "the standard deviation from the
median".INTESTINAL CELL DEATH 185
Equation (2) or (3) is obtained by treating the
median as the mean of a symmetrical distribution
which has been formed by duplicating the right half
on the left (or left half on the right).
This approach was adopted because of the
skewness of many of the distributions but it can
also be applied to symmetrical distributions e.g. if it
were a symmetrical distribution with x (the mean)
and a (the standard deviation from the mean) then
xmed=x and =ui=uv
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